1.Interactive dynamic scalp acupuncture combined with occupational therapy for upper limb motor impairment in stroke: a randomized controlled trial.
Jun WANG ; Jian PEI ; Xiao CUI ; Kexing SUN ; Huanhuan NI ; Cuixia ZHOU ; Ji WU ; Mei HUANG ; Li JI
Chinese Acupuncture & Moxibustion 2015;35(10):983-989
OBJECTIVETo compare the clinical efficacy on upper limb motor impairment in stroke between the interactive dynamic scalp acupuncture therapy and the traditional scalp acupuncture therapy.
METHODSThe randomized controlled trial and MINIMIZE layering randomization software were adopted. Seventy patients of upper limb with III to V grade in Brunnstrom scale after stroke were randomized into an interactive dynamic scalp acupuncture group and a traditional scalp acupuncture group, 35 cases in each one. In the interactive dynamic scalp acupuncture group, the middle 2/5 of Dingnieqianxiexian (anterior oblique line of vertex-temporal), the middle 2/5 of Dingniehouxiexian (posterior oblique line of vertex-temporal) and Dingpangerxian (lateral line 2 of vertex) on the affected side were selected as the stimulation areas. Additionally, the rehabilitation training was applied during scalp acupuncture treatment. In the traditional scalp acupuncture group, the scalp stimulation areas were same as the interactive dynamic scalp acupuncture group. But the rehabilitation training was applied separately. The rehabilitation training was applied in the morning and the scalp acupuncture was done in the afternoon. The results in Fugl-Meyer for the upper limb motor function (U-FMA), the Wolf motor function measure scale (WM- FT) and the modified Barthel index in the two groups were compared between the two groups before treatment and in 1 and 2 months of treatment, respectively.
RESULTSAfter treatment, the U-FMA score, WMFT score and the score of the modified Barthel index were all apparently improved as compared with those before treatment (all P < 0.01). The improvement in the U-FMA score after treatment in the interactive dynamic scalp acupuncture group was better than that in the traditional scalp acupuncture group (P < 0.05). For the patients of IV to V grade in Brunnstrom scale, WMFT score in 2 months of treatment and the score of Barthel index after treatment in the interactive dynamic scalp acupuncture group were improved apparently as compared with those in the traditional scalp acupuncture group (P < 0.05, P < 0.01). But, for the patients of III grade in Brunnstrom scale, WMFT score and the score of Barthel index after treatment in the interactive dynamic scalp acupuncture group were not different significantly as compared with those in the traditional scalp acupuncture group (both P > 0.05).
CONCLUSIONFor the patients of IV to V grade in Brunnstrom scale in stroke, the interactive dynamic scalp acupuncture therapy achieves the superior improvements of the upper limb motor function and the activity of daily life as compared with the traditional scalp acupuncture therapy, and the longer the treatment lasts, the more apparent the improvements are. For the patients of III grade in Brunnstrom scale, the interactive dynamic scalp acupuncture therapy achieves the similar improvement in the upper limb motor impairment as compared with the traditional scalp acupuncture therapy.
Activities of Daily Living ; Acupuncture Points ; Acupuncture Therapy ; Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Occupational Therapy ; Scalp ; Stroke ; physiopathology ; therapy ; Stroke Rehabilitation ; Treatment Outcome ; Upper Extremity ; physiopathology
2.Synthesis and anti alpha-adrenoceptor activity in vitro of 4-((4-((2-substitutedphenoxy)ethyl)-1-piperazinyl) methyl)- 1,2-dihydro-quinoline-2-one compounds.
Hui LIU ; Chong-zhao RAN ; Lin XIA ; Pei-zhou NI
Acta Pharmaceutica Sinica 2002;37(3):181-185
AIMTo study the synthesis and anti alpha-adrenoceptor activity of 1,2-dihydro-quinoline-2-one compounds.
METHODSAcylation, bromination and cyclization, and substitute reactions were used in the synthesis of the title compounds IV. A proposed mechanism was showed to explain the unusual compounds 5 and 6 in the route C. The inhibition activity of the six target compounds were tested.
RESULTSTwelve new compounds were synthesized (II1-6 and IV1-6). Among them, six new compounds (IV1-6) are the title compounds. Structure of the title compounds were determined by IR, 1HNMR, MS and HRMS.
CONCLUSIONCompounds IV3, IV4 and IV6 showed inhibitiion activity, and were worth further studying.
Adrenergic alpha-Antagonists ; chemical synthesis ; pharmacology ; Animals ; Aorta ; drug effects ; In Vitro Techniques ; Molecular Structure ; Phenethylamines ; chemical synthesis ; pharmacology ; Quinolones ; chemical synthesis ; pharmacology ; Rabbits ; Receptors, Adrenergic, alpha ; drug effects ; metabolism ; Technology, Pharmaceutical
3.Protective effects of carnosine against closed head injury in mice.
Xuying PEI ; Kangxin NI ; You ZHOU ; Kun YING ; Xiangnan ZHANG ; Xuyun LI ; Yuan LU ; Zhong CHEN
Journal of Zhejiang University. Medical sciences 2013;42(3):291-296
OBJECTIVETo investigate the protective effects of carnosine against experimental closed head injury (CHI) in mice.
METHODSThe CHI model was established by free-falling weight-drop. Carnosine (250 mg/kg or 500 mg/kg) was administered intraperitoneally 30 min before brain trauma, then q.d for 7 d; while normal saline was administrated for control group. The neurological defect was evaluated by neurological severity score (NSS) within 7 d; the survival rate and the histological alternations were observed.
RESULTSCarnosine prevented the body weight loss of mice at dose of 500 mg/kg; significantly increased the survival rate, and reduced the neurological defect and histological damage at dose of 250 and 500 mg/kg.
CONCLUSIONCarnosine can attenuate closed head injury in mice.
Animals ; Carnosine ; therapeutic use ; Disease Models, Animal ; Head Injuries, Closed ; drug therapy ; pathology ; Male ; Mice ; Mice, Inbred ICR
4.Interventional treatment on bilateral carotid artery pseudoaneurysm rupture bleeding after radiotherapy on a patient with nasopharyngeal carcinoma.
Ling-bo LI ; He-qing HUANG ; Lin LIN ; Ni ZHOU ; Xue-dong LI ; Quan LIU ; Pei-yong HOU
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2013;48(8):687-688
5.Identification of the bacteria strain and its antibiotic resistance in an epidemic of cholera
Xiao-hong ZHOU ; Pei-hua XU ; Yan-jing NI ; Jian CHI ; Xiao-wei ZHU
Shanghai Journal of Preventive Medicine 2021;33(2):128-
Objective The present study was conducted to identify the
6.CYP1A1 rs4646422 gene polymorphisms not correlated with male infertility in Chinese Han population.
Qing ZHOU ; Pei-ran ZHU ; Ming-chao ZHANG ; Jing ZHANG ; Wei-jun JIANG ; Meng-xia NI ; Shuai-mei LIU ; Qiu-yue WU ; Wei-wei LI ; Hao-qin XU ; Xin-yi XIA
National Journal of Andrology 2016;22(5):420-424
OBJECTIVETo determine the correlation of the CYP1A1 (rs4646422) gene polymorphisms with male infertility in the Chinese Han population.
METHODSUsing the Mass ARRAY iPLEX GOLD technique, we conducted a case-control study on theCYPlA1 (rs4646422) gene polymorphisms in 636 infertile males aged 21-49 years (case group) and 442 normal healthy men aged 23-47 years (control group) of the Chinese Han population. We analyzed the genotypes and allele frequencies in the two groups ofsubjects with the SPSS 20.0 software.
RESULTSCompared with the wild homozygous genotype GG, the heterozygous genotype AG (OR = 1.06, 95% CI 0.81-1.38) and homozygous genotype AA (OR = 1.11, 95% CI 0.56-2.21) showed no correlation with male infertility, nor did the mutant allele A (OR = 1.06, 95% CI 0.85-1.32) in comparison with the wild allele G.
CONCLUSIONThe CYP1A1 (rs4646422) gene polymorphisms might not be correlated with male infertility in the Chinese Han population.
Adult ; Alleles ; Case-Control Studies ; China ; Cytochrome P-450 CYP1A1 ; genetics ; Gene Frequency ; Genotype ; Homozygote ; Humans ; Infertility, Male ; genetics ; Male ; Middle Aged ; Polymorphism, Genetic ; Young Adult
7.Progressive huge epidermoid cyst of distal femur in chronic osteomyelitis: a case report and review of literature.
Wei-Feng JI ; Pei-Jian TONG ; Zhen-Chuan MA ; Gui-Bao NI ; Gou-Hua SHEN ; Hai-Long ZHOU ; Xiao-Dong YAO ; Lu-Wei XIAO
China Journal of Orthopaedics and Traumatology 2011;24(12):1027-1029
Bone Diseases
;
etiology
;
surgery
;
Chronic Disease
;
Epidermal Cyst
;
etiology
;
surgery
;
Femur
;
Humans
;
Male
;
Middle Aged
;
Osteomyelitis
;
complications
8.Quantitation of HTLV-I proviral load using real-time quantitative PCR with Taqman MGB probe.
Jin-Zhen XIE ; Chang-Rong CHEN ; Jun ZHANG ; Hong-Ying NI ; Sheng-Xiang GE ; Juan-Juan ZHOU ; Shan-Hai OU ; Xiu-Juan ZHENG ; Peng RAN ; Bin PEI
Chinese Journal of Virology 2009;25(5):339-343
A quantitative real-time PCR assay was developed to measure the proviral load of human T-lymphotropic virus type I (HTLV-I) in peripheral blood. The technology utilizes special primers and Taqman MGB fluorescence probe to measure amplification products from the gag-pro-pol polyprotein gene of HTLV-I. HTLV-I copy number was normalized to the amount of cellular DNA by quantitation of the beta-actin gene, The amplification system was sensitive to detect 5 copy/microL. The standard curve had a good linearity when the quantity for the gene was between 10(3) and 10(7) copy/microL (R2 = 0.999). Good reproducibility was observed in each intra- and inter-assay. We also measured proviral load in peripheral blood in 12 HTLV-I seropositive former blood donors. Proviral load for HTLV-I infected donors ranged from 0.015 to 12.819 copy/cell in WBC with the mean of 3.116 copy/cell.
Gene Products, gag
;
genetics
;
Gene Products, pol
;
genetics
;
Human T-lymphotropic virus 1
;
genetics
;
isolation & purification
;
Humans
;
Molecular Probes
;
Polymerase Chain Reaction
;
methods
;
Viral Proteins
;
genetics
9.Expression of RSK4, CD44 and MMP-9 in metastatic renal cell carcinoma and its correlation with clinicopathologic features
Jing MA ; Zhou YU ; yang Ming LI ; feng Pei LI ; Xia LI ; Zhe WANG ; ni Lin FAN
Chinese Journal of Clinical and Experimental Pathology 2017;33(8):852-857
Purpose To investigate the expression of RSK4 (ribosomal S6 protein kinase 4),CD44 and MMP-9 protein in primary renal cell carcinoma (pRCC) and metastatic renal cell carcinoma (mRCC),and to explore the level of expression as well as the association with clinicopathologic features and clinical outcome.Methods The expression of RSK4,CD44 and MMP-9 in 52 pRCC and 48 mRCC samples was detected by immunohistochemistry and its relationship with clinicopathologic features as well as prognosis was analyzed by statistical methods.Results In the 48 mRCC samples,there were 36 (75%,36/48),33(68.75%,33/48) and 44 (91.7%,44/48) positive for RSK4,CD44 and MMP-9,respectively,while the positive rate in 52 pRCC samples were 23 (44.2%,23/52),18 (34.6%,18/52) and 36 (69.2%,36/52),respectively.Statistical analysis showed that the expression of RSK4,CD44 and MMP-9 in mRCC samples was higher than the pRCC samples (PRsK4 =0.002,PMMP-9 =0.002,PcD44 =0.001).Furthermore,the expression of RSK4,CD44 and MMP-9 in mRCC samples was not correlated with ages,genders,Fuhrman grading and the metastatic sites (P > 0.05).Further analysis showed that there was positive correlation among the three proteins (P =0.008),particularly,the expression of RSK4 and CD44 (P =0.019),MMP-9 and CD44 (P =0.05) were positively correlated,while the expression of RSK4 and MMP-9 (P =1.00) had no significance of correlation.Conclusion The expression of RSK4,CD44 and MMP-9 in mRCC samples is significantly higher than pRCC samples,suggesting that the three may mediate the metastasis of renal cell carcinoma,and its specific mechanism of action remains to be further studied.
10.Phase Ⅱ Clinical Study of Topotecan in Treatment of Patients with Small Cell Lung Cancer: A Multiple Center Clinical Trail
Li ZHANG ; Zhong-Jun XIA ; Zhong-Zhen GUAN ; Pei-Wen LI ; You-Ning LIU ; Xiao-Dian HU ; Qing-Hua ZHOU ; Dian-Tao NI ; Xue-Lan WANG
Chinese Journal of Cancer 2001;20(4):419-422
Objective: The aim of this study was to investigate the efficacy and toxicity of single agent topotecan(second line) or topotecan+ cisplatin (first line) in the treatment of the patients with small cell lung cancer (SCLC). Methods: Ninety-seven patients were evaluated efficacy and toxicity in 100 eligible patients in a multiple center clinical trail. Topotecan was administrated as a second line single agent in 38 relapse SCLC patients and the dose of topotecan was 1.25 mg· ( m2· d) -1 for 5 days and repeat every 3 weeks. Topotecan+ cisplatin regimen was used in the chemonaive SCLC patients and the dose of topotecan was reduced to 1 mg· ( m2· d) -1 for 5 days and the cisplatin was 80 mg· ( m2· d) -1 for one dose. Results: The response rate was 37.5% as second line chemotherapy in relapse SCLC, including complete response of 3.1% and the partial response 34.4. The response rate was 79.6% (complete response,22.4% and partial response,57.1% ) when cisplatin was combined with topotecan in the chemonaive SCLC patients. Bone marrow suppression was the main toxicity of topotecan and Grade Ⅲ -Ⅳ neutropenia and thrombopenia was observed in 39.9% and 31.6% respectively in single agent regimen and 61.0% and 39.9% in combined regimen respectively. The non-hemotological toxicity was mineral. Conclusion: Topotecan may be an effective drugs for the patients with SCLC when used as the first or the second line regimen, and more efficacy when combine with cisplatin. The main toxicity of topotecan is hemotological toxicity.